Swinnzea Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Bangalore South, Karnataka, India, established in 2019.
2019 Bangalore South, Karnataka, India Active
Last Updated:
Access Report
About Swinnzea Pharmaceuticals Private Limited

Swinnzea Pharmaceuticals Private Limited, a active private limited company, was established on 14 March 2019 in Bangalore South, Karnataka, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24230KA2019PTC122375. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.18 M.

Formerly known as Sebakind Private Limited. It upholds a compliant status. Employing 13 professional, Its leadership includes Sathisha Cheekanahalli Raju (Director), Jayalakshmi Devanga Srinivas Murthy (Director). Past directors included Jayalakshmi Devanga Srinivas Murthy, Ravi Ranganath, Gowerder Shashidhar Chethan. It holds ₹5.50 M open charges and no settled loans. Its latest AGM occurred on 19 July 2025, with the balance sheet filed on 31 March 2025. It is based at No 15, 4Th Cross, Manjunath Nagar,, Raghuvanahalli Gate, Opp Metro Pillar No 211,, Bangalore South, Karnataka, 560062.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230KA2019PTC122375

  • Registration Number

    122375

  • Incorporation Date

    14 March 2019

  • Authorized Capital

    ₹0.20 M

  • Paid-Up Capital

    ₹0.18 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.20 M
  • Paid Up Capital ₹ 0.18 M
  • Company Age 6 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 5.50 M
  • Revenue Growth **** 185.45%
  • Profit Growth **** 676.93%
  • Ebitda **** 201.94%
  • Net Worth 79.44%
  • Total Assets **** 108.99%
Company report

Swinnzea Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Swinnzea Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Swinnzea Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Sathisha Cheekanahalli Raju Director 14 Mar 2019 Current
Jayalakshmi Devanga Srinivas Murthy Director 05 Aug 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 28 Sep 2023 Past
Pramod Abcsdd Director 16 Oct 2020 Past
Pramod Abcsdd Director 26 Feb 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Swinnzea Pharmaceuticals.

Swinnzea Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 185.45% increase. The company also saw a substantial improvement in profitability, with a 676.93% increase in profit. The company's net worth Soared by an impressive increase of 79.44%.

Swinnzea Pharmaceuticals revenue growth over time
Swinnzea Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 185.45%
*******
*******
*******
*******
Revenue from Operations
*******
 185.45%
*******
*******
*******
*******
Total Assets
*******
 108.99%
*******
*******
*******
*******
Profit or Loss
*******
 676.93%
*******
*******
*******
*******
Net Worth
*******
 79.44%
*******
*******
*******
*******
EBITDA
*******
 201.94%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Swinnzea Pharmaceuticals?

In 2021, Swinnzea Pharmaceuticals had a promoter holding of 83.40% and a public holding of 16.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹5,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 0.55 Cr
Latest Charge Details
Date Lender Amount Status
04 Nov 2025 Hdfc Bank Limited ₹5.50 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Swinnzea Pharmaceuticals?

Swinnzea Pharmaceuticals has a workforce of 13 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Swinnzea Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swinnzea Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Swinnzea Pharmaceuticals
Recent Activity within the Organization
  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 5.50 M with Charge ID 101183092 was registered on 04 Nov 2025. was completed.

  • Annual General Meeting

    Progress on Swinnzea Pharmaceuticals Private Limited last Annual general meeting of members was held on 19 Jul 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Swinnzea Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.

  • Director Appointment

    Progress on Jayalakshmi Devanga Srinivas Murthy was appointed as a Director was appointed as a Director on 05 Aug 2022 & has been associated with this company since 3 years 6 months . was documented.

  • Director Appointment

    Progress on Sathisha Cheekanahalli Raju was appointed as a Director was appointed as a Director on 14 Mar 2019 & has been associated with this company since 6 years 11 months . was documented.

  • Company Incorporation

    Swinnzea Pharmaceuticals Private Limited was registered on 14 Mar 2019 with Roc Bangalore & aged 6 years 11 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Swinnzea Pharmaceuticals Private Limited?

The CIN of Swinnzea Pharmaceuticals Private Limited is U24230KA2019PTC122375.

Where is Swinnzea Pharmaceuticals Private Limited headquartered?

Swinnzea Pharmaceuticals Private Limited is headquartered at No 15, 4Th Cross, Manjunath Nagar,, Raghuvanahalli Gate, Opp Metro Pillar No 211,, Bangalore South, Karnataka, 560062.

When was Swinnzea Pharmaceuticals Private Limited incorporated?

Swinnzea Pharmaceuticals Private Limited was incorporated on 14 March 2019.

Who are the current directors of Swinnzea Pharmaceuticals Private Limited?

The current directors of Swinnzea Pharmaceuticals Private Limited are

What is the primary industry of Swinnzea Pharmaceuticals Private Limited?

The primary industry of Swinnzea Pharmaceuticals Private Limited is Trade.

Is Swinnzea Pharmaceuticals Private Limited a listed company?

Swinnzea Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Swinnzea Pharmaceuticals Private Limited?

The authorized capital of Swinnzea Pharmaceuticals Private Limited is ₹0.20 M, and the paid-up capital is ₹0.18 M.

What is the compliance status of Swinnzea Pharmaceuticals Private Limited?

The compliance status of Swinnzea Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available